Kuchyne na miru

Top Feature

Jul 15, 2019
Pharmaceutical Executive
Big pharma compliance leaders Bryant Aaron (Novartis) and Jennifer McGee (Otsuka) discuss the strategic move to principles-based policies at their companies and the impact of other emerging forces influencing industry compliance practice.
Jul 14, 2019
Pharmaceutical Executive
A look at some of the key pharma compliance challenges prevalent in the Asia-Pacific region.
Jul 12, 2019
Pharmaceutical Executive
Our 19th annual listing reveals some interesting maneuvering of ranks, as companies focus on diversification, big-brand expansions, and positioning a new wave of products to compete in an advancing but complex future treatment market.
Jul 11, 2019
Pharmaceutical Executive
Daniel Manea, Novartis’s US head of people and organization, talks about how the company’s cultural transformation aims to strengthen and empower its talent base.
Jul 09, 2019
Pharmaceutical Executive
A review of market performance and trends in 2018 and first quarter of 2019 for the life sciences industry.
Jul 02, 2019
Bruno Wohlschlegel, European head of Merck KGaA, Darmstadt, Germany's Healthcare business, outlines the highlights of his career and talks about how his vision for Europe draws strength from the region’s diversity to advance collaboration and progress.
Jun 24, 2019
Pharmaceutical Executive
Robert Groebel offers six ways pharma MA departments can drive more collaborative relationships with caregivers.
Jun 21, 2019
Chris Round, Head of International Operations & Global Core Franchises at Merck KGaA, Darmstadt, Germany, talks to Pharm Exec about his role in advancing the company’s “double mission."
Jun 11, 2019
Pharmaceutical Executive
With little momentum in developing new antibiotics to fight antimicrobial resistance, writes Dave Roblin, the time is now to emphasize "push" and "pull" incentives and demonstrate how innovation in this area will lead to patient benefit and economic reward.
May 13, 2019
Pharmaceutical Executive
Exploring the rise of environmental, social, and governance investing and venture philanthropy in accelerating drug development.

Facebook targeted ads www.progressive.ua
lorem ipsum